Progress Toward Regional Measles Elimination — Worldwide, 2000–2020

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Dixon, Meredith G. ; Ferrari, Matt ; Antoni, Sebastien ; Li, Xi ; Portnoy, Allison ; Lambert, Brian ; Hauryski, Sarah ; Hatcher, Cynthia ; Nedelec, Yoann ; Patel, Minal ; Alexander, James P. ; Steulet, Claudia ; Gacic-Dobo, Marta ; Rota, Paul A. ; Mulders, Mick N. ; Bose, Anindya S. ; Rosewell, Alexander ; Kretsinger, Katrina ; Crowcroft, Natasha S.
• Description:
  In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles| in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030)| uses measles incidence as an indicator of the strength of immunization systems. The Measles-Rubella Strategic Framework 2021-2030| and the Measles Outbreaks Strategic Response Plan 2021-2023** are aligned with the IA2030 and highlight robust measles Surveillance systems to document immunity gaps, identify root causes of undervaccination, and develop locally tailored solutions to ensure administration of 2 doses of measles-containing vaccine (MCV) to all children. This report describes progress toward World Health Assembly milestones and measles elimination objectives during 2000-2020 and updates a previous report (2). During 2000-2010, estimated MCV first dose (MCV1) coverage increased globally from 72% to 84%, peaked at 86% in 2019, but declined to 84% in 2020 during the COVID-19 pandemic. All countries conducted measles Surveillance, although fewer than one third achieved the sensitivity indicator target of ≥2 discarded| cases per 100,000 population in 2020. Annual reported measles incidence decreased 88% during 2000-2016, from 145 to 18 cases per 1 million population, rebounded to 120 in 2019, before falling to 22 in 2020. During 2000-2020, the annual number of estimated measles deaths decreased 94%, from 1,072,800 to 60,700, averting an estimated 31.7 million measles deaths. To achieve regional measles elimination targets, enhanced efforts are needed to reach all children with 2 MCV doses, implement robust Surveillance, and identify and close immunity gaps.
• Subjects:
  Child Disease Eradication Global Health Humans Immunization Programs Incidence Infant Measles Measles Vaccine
• Source:
  MMWR Morbidity Mortal Weekly Rep. 70(45):1563-1569
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/MMWRmm7045a1
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  34758014
• Pubmed Central ID:
  PMC8580203
• Document Type:
  Journal Article
• Pages in Document:
  7 pdf pages
• Volume:
  70
• Issue:
  45
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:f7681c31f032eeb412b4ee83495526caf3079b7e5f4fce89dc596fde09c04089d6cbe07415e5f8f5c7251e5bd97d31eee8136c38049a2233200f27571a9cc393
• Download URL:
  https://stacks.cdc.gov/view/cdc/111851/cdc_111851_DS1.pdf
• File Type:
  [PDF - 205.52 KB ]